Inhibition of receptor/G protein coupling by suramin analogues

W Beindl, T Mitterauer, M Hohenegger, AP Ijzerman, C Nanoff and M Freissmuth

Institute of Pharmacology, Vienna University, Austria.

Suramin analogues act as direct antagonists of heterotrimeric G proteins because they block the rate-limiting step of G protein activation (i.e., the dissociation of GDP prebound to the G protein alpha subunit). We have used the human brain A1 adenosine receptor and the rat striatal D2 dopamine receptor, two prototypical Gi/G(o)-coupled receptors, as a model system to test whether the following analogues suppress the receptor-dependent activation of G proteins: 8-(3- nitrobenzamido)-1,3,5-naphthalenetrisulfonic acid (NF007), 8-(3-(3- nitrobenzamido)-benzamido)-1,3,5-naphthalenetrisulfonic acid (NF018); 8,8'-(carbonylbis(imino-3,1-phenylene))bis-(1,3,5-naphthalenetr isulfonic acid) (NF023); 8,8'-(carbonylbis(imino-3,1- phenylene)carbonylimino-(3,1- phenylene)) bis(1,3,5- naphthalenetrisulfonic acid) (NF037); and suramin. Suramin and its analogues inhibit the formation of the agonist-specific ternary complex (agonist/receptor/G protein). This inhibition is (i) quasicompetitive with respect to agonist binding in that it can be overcome by increasing receptor occupancy but (ii) does not result from an interaction of the analogues with the ligand binding pocket of the receptors because the binding of antagonists or of agonists in the absence of functional receptor/G protein interaction is not affected. In addition to suppressing the spontaneous release of GDP from defined G protein alpha subunits, suramin and its analogues reduce receptor- catalyzed guanine nucleotide exchange. The site, to which suramin analogues bind, overlaps with the docking site for the receptor on the G protein alpha subunit. The structure-activity relationships for inhibition of agonist binding to the A1 adenosine receptor (suramin > NF037 > NF023) and of agonist binding to the inhibition D2 dopamine receptor (suramin = NF037 > NF023 > NF018) differ. Thus, NF037 discriminates between the ternary complexes formed by the agonist- liganded D2 dopamine receptors and those formed by the A1 adenosine receptor with > 10-fold selectivity. Therefore, our results also show that inhibitors can be identified that selectively uncouple specific receptor/G protein tandems.

Volume 50, Issue 2, pp. 415-423, 08/01/1996
Copyright © 1996 by American Society for Pharmacology and Experimental Therapeutics

This article has been cited by other articles:

				A. Sen, L. Lv, N. Bello, J. J. Ireland, and G. W. Smith Cocaine- and Amphetamine-Regulated Transcript Accelerates Termination of Follicle-Stimulating Hormone-Induced Extracellularly Regulated Kinase 1/2 and Akt Activation by Regulating the Expression and Degradation of Specific Mitogen-Activated Protein Kinase Phosphatases in Bovine Granulosa Cells Mol. Endocrinol., December 1, 2008; 22(12): 2655 - 2676. [Abstract] [Full Text] [PDF]

				M. Hou, L. Duan, and M. M. Slaughter Synaptic inhibition by glycine acting at a metabotropic receptor in tiger salamander retina J. Physiol., June 15, 2008; 586(12): 2913 - 2926. [Abstract] [Full Text] [PDF]

				L.-Y. Fu and A. N. van den Pol Agouti-Related Peptide and MC3/4 Receptor Agonists Both Inhibit Excitatory Hypothalamic Ventromedial Nucleus Neurons J. Neurosci., May 21, 2008; 28(21): 5433 - 5449. [Abstract] [Full Text] [PDF]

				H. Katayama, Y. Kusaka, H. Yokota, T. Akao, M. Kojima, O. Nakamura, E. Mekada, and E. Mizuki Parasporin-1, a Novel Cytotoxic Protein from Bacillus thuringiensis, Induces Ca2+ Influx and a Sustained Elevation of the Cytoplasmic Ca2+ Concentration in Toxin-sensitive Cells J. Biol. Chem., March 9, 2007; 282(10): 7742 - 7752. [Abstract] [Full Text] [PDF]

				G. P. Prevost, M. O. Lonchampt, S. Holbeck, S. Attoub, D. Zaharevitz, M. Alley, J. Wright, M. C. Brezak, H. Coulomb, A. Savola, et al. Anticancer Activity of BIM-46174, a New Inhibitor of the Heterotrimeric G{alpha}/G{beta}{gamma} Protein Complex. Cancer Res., September 15, 2006; 66(18): 9227 - 9234. [Abstract] [Full Text] [PDF]

				V. Verma, A. Mann, W. Costain, G. Pontoriero, J. M. Castellano, K. Skoblenick, S. K. Gupta, Z. Pristupa, H. B. Niznik, R. L. Johnson, et al. Modulation of Agonist Binding to Human Dopamine Receptor Subtypes by L-Prolyl-L-leucyl-glycinamide and a Peptidomimetic Analog J. Pharmacol. Exp. Ther., December 1, 2005; 315(3): 1228 - 1236. [Abstract] [Full Text] [PDF]

				W.-C. Chung and J. C. Kermode Suramin Disrupts Receptor-G Protein Coupling by Blocking Association of G Protein {alpha} and {beta}{gamma} Subunits J. Pharmacol. Exp. Ther., April 1, 2005; 313(1): 191 - 198. [Abstract] [Full Text] [PDF]

				F. Li, M. De Godoy, and S. Rattan Role of Adenylate and Guanylate Cyclases in {beta}1-, {beta}2-, and {beta}3-Adrenoceptor-Mediated Relaxation of Internal Anal Sphincter Smooth Muscle J. Pharmacol. Exp. Ther., March 1, 2004; 308(3): 1111 - 1120. [Abstract] [Full Text] [PDF]

				E. J. Cotter, N. v. O. Sweeney, P. M. Coen, Y. A. Birney, M. J. Glucksman, P. A. Cahill, and P. M. Cummins Regulation of Endopeptidases EC3.4.24.15 and EC3.4.24.16 in Vascular Endothelial Cells by Cyclic Strain: Role of Gi Protein Signaling Arterioscler. Thromb. Vasc. Biol., March 1, 2004; 24(3): 457 - 463. [Abstract] [Full Text]

				E. K.-W. Hui and D. P. Nayak Role of G protein and protein kinase signalling in influenza virus budding in MDCK cells J. Gen. Virol., December 1, 2002; 83(12): 3055 - 3066. [Abstract] [Full Text] [PDF]

				A. Christopoulos and T. Kenakin G Protein-Coupled Receptor Allosterism and Complexing Pharmacol. Rev., June 1, 2002; 54(2): 323 - 374. [Abstract] [Full Text] [PDF]

				E. Breitweg-Lehmann, C. Czupalla, R. Storm, O. Kudlacek, W. Schunack, M. Freissmuth, and B. Nurnberg Activation and Inhibition of G Proteins by Lipoamines Mol. Pharmacol., March 1, 2002; 61(3): 628 - 636. [Abstract] [Full Text] [PDF]

				A. B. Fawzi, D. Macdonald, L. L. Benbow, A. Smith-Torhan, H. Zhang, B. C. Weig, G. Ho, D. Tulshian, M. E. Linder, and M. P. Graziano SCH-202676: An Allosteric Modulator of Both Agonist and Antagonist Binding to G Protein-Coupled Receptors Mol. Pharmacol., January 1, 2001; 59(1): 30 - 37. [Abstract] [Full Text]

				C. P. Hodgkinson, M. C. Wright, and A. J. Paine Fibronectin-Mediated Hepatocyte Shape Change Reprograms Cytochrome P450 2C11 Gene Expression via an Integrin-Signaled Induction of Ribonuclease Activity Mol. Pharmacol., November 1, 2000; 58(5): 976 - 981. [Abstract] [Full Text]

				F. Roka, L. Brydon, M. Waldhoer, A. D. Strosberg, M. Freissmuth, R. Jockers, and C. Nanoff Tight Association of the Human Mel1a-Melatonin Receptor and Gi: Precoupling and Constitutive Activity Mol. Pharmacol., November 1, 1999; 56(5): 1014 - 1024. [Abstract] [Full Text]

				V. Ralevic and G. Burnstock Receptors for Purines and Pyrimidines Pharmacol. Rev., September 1, 1998; 50(3): 413 - 492. [Abstract] [Full Text] [PDF]

				A. Gilchrist, M. R. Mazzoni, B. Dineen, A. Dice, J. Linden, W. R. Proctor, C. R. Lupica, T. V. Dunwiddie, and H. E. Hamm Antagonists of the Receptor-G Protein Interface Block Gi-coupled Signal Transduction J. Biol. Chem., June 12, 1998; 273(24): 14912 - 14919. [Abstract] [Full Text] [PDF]

				B. F. King, S. S. Wildman, A. Townsend-Nicholson, and G. Burnstock Antagonism of an Adenosine/ATP Receptor in Follicular Xenopus Oocytes J. Pharmacol. Exp. Ther., June 1, 1998; 285(3): 1005 - 1011. [Abstract] [Full Text]

				M. Waldhoer, E. Bofill-Cardona, G. Milligan, M. Freissmuth, and C. Nanoff Differential Uncoupling of A1 Adenosine and D2 Dopamine Receptors by Suramin and Didemethylated Suramin (NF037) Mol. Pharmacol., May 1, 1998; 53(5): 808 - 818. [Abstract] [Full Text]

				R. O. Arellano, E. Garay, and R. Miledi Cl- currents activated via purinergic receptors in Xenopus follicles Am J Physiol Cell Physiol, February 1, 1998; 274(2): C333 - C340. [Abstract] [Full Text] [PDF]

				M. Hohenegger, M. Waldhoer, W. Beindl, B. Boing, A. Kreimeyer, P. Nickel, C. Nanoff, and M. Freissmuth Gsalpha-selective G protein antagonists. PNAS, January 6, 1998; 95(1): 346 - 351. [Abstract] [Full Text] [PDF]

				C. K. Szekeres, K. Tang, M. Trikha, and K. V. Honn Eicosanoid Activation of Extracellular Signal-regulated Kinase1/2 in Human Epidermoid Carcinoma Cells J. Biol. Chem., December 1, 2000; 275(49): 38831 - 38841. [Abstract] [Full Text] [PDF]